Mayne Pharma Group Limited
Mayne Pharma Group Limited (MAYNF) Revenue
Annual & quarterly revenue history · segment & region breakdown
MAYNF · revenue · updated Jun 9, 2026
Core revenue metrics
Trailing 12 monthsMayne Pharma Group Limited trailing twelve-month (TTM) revenue is $0.82B, an increase of 0.00% year-over-year from — in FY.
Revenue trend
– · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Mayne Pharma Group Limited receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Mayne Pharma Group Limited reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Mayne Pharma Group Limited's 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
MAYNF revenue · 4 questionsMAYNF's trailing twelve-month (TTM) revenue is $0.82B. That is an increase of 0.00% year-over-year from — in FY.
▸ Source: FMP · Mayne Pharma Group Limited SEC filings · GAAP · Mayne Pharma Group Limited SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026